Revenio Group Oyj Logo

Revenio Group Oyj

Develops ophthalmic devices and software for early detection of significant eye diseases.

REG1V | HE

Overview

Corporate Details

ISIN(s):
FI0009010912
LEI:
743700I27E0FWSXLKK04
Country:
Finland
Address:
Äyritie 22, FI-01510 VANTAA
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Revenio Group Oyj is a leading global company in the market for ophthalmological devices and software solutions. The company specializes in health technology, developing and commercializing effective and easy-to-use screening devices for the early detection of significant eye diseases. Under its trusted iCare brand, Revenio provides a comprehensive portfolio of ophthalmic diagnostic solutions, including intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters. These are complemented by clinical software and digital tools that enhance efficiency and quality in eye care. Revenio's products offer physicians fast and reliable methods for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD), positioning iCare as a key partner in the eye care industry.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-30 08:05
Report Publication Announcement
Revenio Group Oyj:n taloudellinen tiedottaminen ja yhtiökokous vuonna 2026
Finnish 2.6 KB
2025-10-30 08:05
Report Publication Announcement
Revenio Group Corporation's financial reporting and Annual General Meeting in 2…
English 2.7 KB
2025-10-30 08:00
Earnings Release
Revenio Group Oyj: Osavuosiraportti 1.1.-30.9.2025
Finnish 11.9 KB
2025-10-30 08:00
Earnings Release
Revenio Group Corporation: Interim report January 1- September 30, 2025
English 13.1 KB
2025-08-07 08:00
Earnings Release
Revenio Group Oyj: Puolivuosikatsaus 1.1.-30.6.2025
Finnish 11.3 KB
2025-08-07 08:00
Earnings Release
Revenio Group Corporation: Half-year report January 1-June 30, 2025
English 12.7 KB
2025-05-15 08:00
Remuneration Information
Revenio Groupin hallitus päätti pitkän aikavälin kannustinjärjestelmän ansainta…
Finnish 3.8 KB
2025-05-15 08:00
Remuneration Information
Revenio Group Corporation's Board of Directors resolved on the long-term incent…
English 3.8 KB
2025-05-14 15:00
Director's Dealing
Revenio Group Oyj: Johdon liiketoimet - Aanat Loewenstein
Finnish 2.1 KB
2025-05-14 15:00
Director's Dealing
Revenio Group Corporation: Managers' Transactions - Anat Loewenstein
English 2.1 KB
2025-05-14 15:00
Director's Dealing
Revenio Group Oyj: Johdon liiketoimet - Heli Lindfors
Finnish 2.1 KB
2025-05-14 15:00
Director's Dealing
Revenio Group Corporation: Managers' Transactions - Heli Lindfors
English 2.0 KB
2025-05-14 15:00
Director's Dealing
Revenio Group Oyj: Johdon liiketoimet - Ann-Christine Sundell
Finnish 2.1 KB
2025-05-14 15:00
Director's Dealing
Revenio Group Corporation: Managers' Transactions - Ann-Christine Sundell
English 2.1 KB
2025-05-14 15:00
Director's Dealing
Revenio Group Oyj: Johdon liiketoimet - Riad Sherif
Finnish 2.0 KB

Automate Your Workflow. Get a real-time feed of all Revenio Group Oyj filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Revenio Group Oyj

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Revenio Group Oyj via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
3-D Matrix,Ltd. Logo
Develops peptide-based medical devices for surgical bleeding control and wound healing.
Japan 7777
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France ABLD
Adagio Medical Holdings, Inc. Logo
Develops ultra-low temp cryoablation catheters for cardiac arrhythmia treatment.
United States of America ADGM
Advanced Biomed Inc. Logo
Develops microfluidic biochips for rapid, affordable liquid biopsy in precision oncology.
United States of America ADVB
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom AMS
AETHLON MEDICAL INC Logo
Develops a blood-filtering device to combat resistant cancers and life-threatening viruses.
United States of America AEMD
Affluent Medical Logo
Developing minimally invasive, restorative implants for structural heart disease and urology.
France AFME
Ainos, Inc. Logo
Develops AI-powered 'SmellTech' diagnostics and immune therapies for point-of-care testing.
United States of America AIMD
AIOBIO Co., Ltd. Logo
Develops AI biofluorescence dental tools for early detection of caries and plaque.
South Korea 447690

Talk to a Data Expert

Have a question? We'll get back to you promptly.